Sean Smith is the founder of ImmunOs Therapeutics. ImmunOs Therapeutics has raised $89M in total funding. Latest round: Series B.
Sean R. Smith is the CEO of ImmunOs Therapeutics AG, a Swiss biopharmaceutical company founded in 2014. He led the company through its Series A and Series B financing rounds. Following the Series B close, he established a U.S. subsidiary for ImmunOs Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide